文献速递神经免疫认知障碍与痴呆

脊髓萎缩影像学:HTLV-I相关神经疾病与多发性硬化

Imaging spinal cord atrophy in progressive myelopathies: HTLV-I-associated neurological disease (HAM/TSP) and multiple sclerosis (MS).
PubMed 文献 · Ann Neurol · 2017-11-08

本研究测量了健康对照、HTLV-1无症状携带者、HAM/TSP患者及不同型多发性硬化患者的颈胸段脊髓横截面积,发现HAM/TSP和进展型MS存在显著脊髓萎缩,且HAM/TSP的临床残疾评分、CD8+ T细胞频率及脑脊液HTLV-1前病毒载量与胸段脊髓横截面积相关。

要点

  • HAM/TSP患者颈胸段脊髓横截面积显著小于健康对照和无症状携带者。
  • 继发进展型和原发进展型MS患者颈髓横截面积小于健康对照和复发缓解型MS。
  • HAM/TSP中胸段脊髓萎缩与残疾评分、CD8+ T细胞频率及脑脊液前病毒载量相关。

核心结论

  • HAM/TSP和进展型MS患者组平均脊髓横截面积显示脊髓萎缩。
  • HAM/TSP中胸段炎症过程导致的神经胶质丢失可能引起轴突变性和胸段至颈段萎缩的时间进展。

研究设计与样本

  • 横断面研究,纳入24名健康对照、17名HTLV-1无症状携带者、47名HAM/TSP、74名复发缓解型MS、17名继发进展型MS和40名原发进展型MS。
  • 从C1至T10测量脊髓横截面积,并与临床残疾评分、病毒标志物和免疫参数进行相关性分析。
  • 对2名HAM/TSP患者进行了为期3年的纵向脊髓横截面积测量。

主要发现

  • HAM/TSP患者C2-C3、C4-C5、T4-T9脊髓横截面积分别为56 mm2(标准差10)、59(10)、23(5),小于健康对照的76(7)、83(8)、38(4)和无症状携带者的71(7)、78(9)、36(7)。
  • 继发进展型MS对应区域面积为62(9)、66(9)、32(6),原发进展型MS为65(11)、68(10)、35(7),均小于健康对照和复发缓解型MS的73(9)、77(10)、37(6)。
  • HAM/TSP中扩展残疾状态量表(p=0.009)、Cananeia研究机构评分(p=0.03)和CD8+ T细胞频率(p=0.04)与T4-T9脊髓横截面积相关。
  • 脑脊液HTLV-1前病毒载量较高(p=0.01)与更薄的脊髓横截面积相关。
  • 2名纵向随访的HAM/TSP患者均先出现胸段脊髓变薄,随后出现颈段变薄。

临床怎么用

  • 定量脊髓横截面积测量有助于表征HAM/TSP和进展型MS的脊髓萎缩模式。
  • 在HAM/TSP中,胸段脊髓横截面积可作为与临床残疾和免疫病毒学指标相关的影像学标记。

局限性

  • 纵向随访仅纳入2名HAM/TSP患者,样本量小。
  • 研究为观察性设计,无法确定脊髓萎缩与炎症过程的因果关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Previous work measures spinal cord thinning in chronic progressive myelopathies, including human T-lymphotropic virus 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and multiple sclerosis (MS). Quantitative measurements of spinal cord atrophy are important in fully characterizing these and other spinal cord diseases. We aimed to investigate patterns of spinal cord atrophy and correlations with clinical markers. METHODS: Spinal cord cross-sectional area was measured in individuals (24 healthy controls [HCs], 17 asymptomatic carriers of HTLV-1 (AC), 47 HAM/TSP, 74 relapsing-remitting MS [RRMS], 17 secondary progressive MS [SPMS], and 40 primary progressive MS [PPMS]) from C1 to T10. Clinical disability scores, viral markers, and immunological parameters were obtained for patients and correlated with representative spinal cord cross-sectional area regions at the C2 to C3, C4 to C5, and T4 to T9 levels. In 2 HAM/TSP patients, spinal cord cross-sectional area was measured over 3 years. RESULTS: All spinal cord regions are thinner in HAM/TSP (56 mm2 [standard deviation, 10], 59 [10], 23 [5]) than in HC (76 [7], 83 [8], 38 [4]) and AC (71 [7], 78 [9], 36 [7]). SPMS (62 [9], 66 [9], 32 [6]) and PPMS (65 [11], 68 [10], 35 [7]) have thinner cervical cords than HC and RRMS (73 [9], 77 [10], 37 [6]). Clinical disability scores (Expanded Disability Status Scale [p = 0.009] and Instituto de Pesquisas de Cananeia [p = 0.03]) and CD8+ T-cell frequency (p = 0.04) correlate with T4 to T9 spinal cord cross-sectional area in HAM/TSP. Higher cerebrospinal fluid HTLV-1 proviral load (p = 0.01) was associated with thinner spinal cord cross-sectional area. Both HAM/TSP patients followed longitudinally showed thoracic thinning followed by cervical thinning. INTERPRETATION: Group average spinal cord cross-sectional area in HAM/TSP and progressive MS show spinal cord atrophy. We further hypothesize in HAM/TSP that is possible that neuroglial loss from a thoracic inflammatory process results in anterograde and retrograde degeneration of axons, leading to the temporal progression of thoracic to cervical atrophy described here. Ann Neurol 2017;82:719-728.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Azodi S, Nair G, Enose-Akahata Y, et al. Imaging spinal cord atrophy in progressive myelopathies: HTLV-I-associated neurological disease (HAM/TSP) and multiple sclerosis (MS). Ann Neurol. 2017. PMID: 29024167. doi:10.1002/ana.25072

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。